CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.
about
Some basic aspects of HLA-G biologyThe dual role of HLA-G in cancerLymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathwaySynthetic HLA-G proteins for therapeutic use in transplantation.HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients.Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation.Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantationThe role of HLA-G in immunity and hematopoiesis.HLA-G as a tolerogenic molecule in transplantation and pregnancy.Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditionsExpression of human leukocyte antigen-G and acute rejection in patients following liver transplantationHLA Class Ib Molecules and Immune Cells in Pregnancy and PreeclampsiaLevels of soluble human leukocyte antigen-G are increased in asthmatic airways.HLA-G UTR haplotype conservation in the Malian population: association with soluble HLA-G.Neutrophil gelatinase-associated lipocalin increases HLA-G(+)/FoxP3(+) T-regulatory cell population in an in vitro model of PBMC.Identification of a novel HLA-G+ regulatory population in blood: expansion after allogeneic transplantation and de novo HLA-G expression at graft-versus-host disease sitesImmunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell primingHuman leukocyte antigen-G expression in differentiated human airway epithelial cells: lack of modulation by Th2-associated cytokines.Polymorphic variants in exon 8 at the 3' UTR of the HLA-G gene are associated with septic shock in critically ill patientsEmerging topics and new perspectives on HLA-G.HLA-G in organ transplantation: towards clinical applications.Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy.New insights into HLA-G mediated tolerance.Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker.Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients.The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology.Trogocytic intercellular membrane exchanges among hematological tumors.HLA-G1 and HLA-G5 active dimers are present in malignant cells and effusions: the influence of the tumor microenvironment.HLA-G expression levels influence the tolerogenic activity of human DC-10.Interaction among smoking status, single nucleotide polymorphisms and markers of systemic inflammation in healthy individuals.Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study.CD8(low)CD28(-) T Cells: A Human CD8 T-Suppressor Subpopulation With Alloantigen Specificity Induced by Soluble HLA-A2 Dimer In Vitro.Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.Elimination of CD4HLA-G T cells overcomes castration-resistance in prostate cancer therapy
P2860
Q26852671-8AE3EDB5-52A1-4BC1-A8D3-CAA160F4C996Q26860886-C0564E94-6427-425F-B855-FD9A3A0262FEQ28476661-A9B1C650-C01A-47AF-9621-C7143FDCBAC0Q30543621-8893AFA1-0E5C-4089-A157-2FFA7416C255Q33558697-F5438777-46F2-492F-B3E8-CB63474AC77AQ33574118-ECEDEC4B-25C6-4853-AAFA-16949E68BA2FQ33916474-7CD77713-DC49-411A-86C4-B5E91775F383Q33961715-D9652991-E1C0-4D61-8708-61D58A5B4389Q34024865-75538BFE-9BF6-4A60-A705-DFD23F1BB2CDQ34038019-3833E19E-0026-4491-8768-2129B6D08A02Q34093041-00B125C8-8BB6-494F-A6D3-0AEF6071E195Q34119646-6CF7AA55-3196-435E-9F03-4BF75E6ADF84Q34763454-9681554B-E5D5-4021-9717-5C349501A18CQ34848531-897A9C86-93BC-4013-9DBA-A07FBD7C257BQ35077614-1C4D0D5F-FF0D-45FA-AD4D-680ACE28DB48Q35107474-D2D85C06-8A31-4FBF-BFAE-43080FFF03D6Q36216198-86C918B5-1AAA-483A-9EF3-9967A5080C9DQ36414778-18C5780E-D8C7-45D1-B694-83DA184687E2Q36575385-BCB1FB7A-2ECE-4E10-8252-AF9FCDB6F690Q36928286-C28CF765-4198-4746-BB0D-213AE3A7DD95Q37809764-CC80BB2B-4096-446A-975C-86DE66B49EB4Q37811950-08CB9FEE-564A-4A71-9419-125C13BA2B05Q38127160-FE777C2E-846B-4596-BFAA-BC799D329C52Q38240763-365209E0-7DF8-4BB1-AC00-27DB2EB45FFAQ38839474-C9F76C97-CFB3-4201-8A09-8B887086B6FAQ38863681-D04272CB-31ED-4FA1-B9A4-25C52C37D0CDQ38864796-A03967BA-05E4-4F41-87B9-C4370E198D85Q38885565-7D02C300-9DBB-44E5-AAD5-E92186A8423CQ39334954-19E30FEA-A27F-42AC-8350-0F26D825C5AEQ41465101-A56E9644-9BAE-4E6B-A822-B975DCC7232FQ47400167-12D9ED40-BCE5-4367-8772-8B0EB75A5C3FQ47737681-015D7A79-D23B-4A25-9F04-E5EC19A6A8B3Q51056253-609613CB-6DBC-4C56-BD5A-4D55E02EF499Q53064214-1A621AE6-579B-4303-BDC3-C7047808C93BQ57293807-23AB22BB-7FF6-4877-BCE0-A640C01A188F
P2860
CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
CD3+CD4low and CD3+CD8low are ...... lved in transplant acceptance.
@ast
CD3+CD4low and CD3+CD8low are ...... lved in transplant acceptance.
@en
CD3+CD4low and CD3+CD8low are ...... lved in transplant acceptance.
@nl
type
label
CD3+CD4low and CD3+CD8low are ...... lved in transplant acceptance.
@ast
CD3+CD4low and CD3+CD8low are ...... lved in transplant acceptance.
@en
CD3+CD4low and CD3+CD8low are ...... lved in transplant acceptance.
@nl
prefLabel
CD3+CD4low and CD3+CD8low are ...... lved in transplant acceptance.
@ast
CD3+CD4low and CD3+CD8low are ...... lved in transplant acceptance.
@en
CD3+CD4low and CD3+CD8low are ...... lved in transplant acceptance.
@nl
P2093
P1433
P1476
CD3+CD4low and CD3+CD8low are ...... olved in transplant acceptance
@en
P2093
Abderrahim Naji
Antoine Durrbach
Caroline Creput
Edgardo D Carosella
Irene Krawice-Radanne
Julien Caumartin
Marina Daouya
Nathalie Rouas-Freiss
Solene Le Rond
P304
P356
10.1182/BLOOD-2007-04-083139
P407
P577
2007-09-05T00:00:00Z